Current Surgical Inc., a medical technology company working to revolutionize the safety and efficacy of cancer surgery, has been awarded a remarkable $400,000 grant from the National Institutes of Health.
The grant, provided by the National Cancer Institute, will be used to further develop and test the company’s highly innovative surgical platform in a preclinical study. With this additional support, Current Surgical Inc. is poised to make a powerful impact in the fight against cancer.
Cancer is a dangerous and pervasive disease that claims millions of lives around the world annually, with over 18 million new diagnoses in the past year alone. Despite increased detection in the early stages, therapeutic treatments available have yet to bring about the paradigm shifting advancements we need to make a real impact on this global menace. Now is the time to redouble our efforts and fight until the battle against cancer is won.
Current Surgical is revolutionizing tumor treatment with their smart surgical needle technology. Combining high-resolution sensors and real-time image analysis, the tool enables doctors to quickly and accurately target and eliminate tumors with unprecedented precision.
This means that people of all ages and locations can now be freed from the bounds of traditional surgery and receive curative treatment in a much more efficient and effective way. With this groundbreaking technology, surgeons can now tackle any solid tumor with confidence, and millions of lives can now be saved.
We are delighted to have been awarded this grant from the NCI. This is a huge step forward for Current Surgical and allows us to rapidly progress the development of our platform, putting it into the hands of patients that need it as soon as possible. Al Mashal, CEO of Current Surgical, shares our enthusiasm for this ground-breaking opportunity.
Through the support of the National Cancer Institute, Current Surgical is closer than ever to revolutionizing the world of cancer surgery. Our cutting-edge technology has the power to transform and enhance surgical procedures, and this funding will take us that much closer to making this essential vision a reality.
Surgical technology is revolutionizing the way doctors operate, enabling them to work more efficiently and effectively while putting the patient’s health first. By automating certain complex procedures, doctors can dedicate their full attention to exploring the best possible treatment plan for challenging medical conditions such as cardiac arrhythmias, hypertension, and chronic pain. These innovative tech solutions are helping to improve outcomes while making surgery more accessible to those in need.
About Current Surgical
Current Surgical is revolutionizing cancer surgery with a revolutionary software-enabled surgical platform! Utilizing the power of artificial intelligence, this pioneering technology automates key steps of the surgical process for improved accuracy and precision. The benefits? Reduced risk of complications and improved safety and efficacy for cancer patients. Get ready for a revolutionary leap forward in cancer surgery with Current Surgical!
About the National Cancer Institute (NCI)
NCI is spearheading the National Cancer Program and NIH’s mission to reduce cancer’s prevalence and make the lives of those living with cancer and their families significantly better. To reach this goal, research aims to identify ways to prevent cancer as well as to understand its biology. On top of this, NCI is proactively developing new interventions and training and mentoring aspiring researchers.
About the National Institutes of Health (NIH)
The National Institutes of Health (NIH) is the United States’ go-to medical research agency. Every day, this powerhouse of scientific knowledge works hard to uncover the mysteries behind sickness and disease.
Scientists working under the umbrella of the NIH’s 27 Institutes and Centers are dedicated to the advancement of medical research, from fundamental studies to clinical trials and treatments. Funded by the Department of Health and Human Services, the NIH is a leader in finding cures for both common and rare diseases.